Search in:

OncoImmunology Volume 5, 2016 - Issue 5

Submit an article Journal homepage

Open access

1,632

Views

CrossRef citations to date

Altmetric

Review

Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumors

Alexander K. TsaiMarlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Baltimore, MD, USA

Eduardo DavilaMarlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Baltimore, MD, USA;Department of Microbiology and Immunology, University of Maryland, Baltimore, Baltimore, MD, USACorrespondence[email protected]

Article: e1122158 | Received 14 Aug 2015, Accepted 14 Nov 2015, Published online: 19 Apr 2016

Cite this article
https://doi.org/10.1080/2162402X.2015.1122158
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (16)

彦子厉. (2023) Research Status and Progress on the Expression of CD4+, CD8+T Lymphocyte Subsets in Tumor. Advances in Clinical Medicine 13:07, pages 10720-10726.
Crossref

Yanzi Li, Hongying Lv, Donghai Liang, Tao Jiang, Wei Zhao, Fei Zhou, Chenchen Jiao, Yuyuan Zhou & Hongsheng Yu. (2022) Effects of Low-dose Splenic Irradiation on T lymphocyte Immune Function. Health Physics 123:6, pages 486-491.
Crossref

彦子厉. (2022) Effects of Low Dose Splenic Region Irradiation and Low Dose Total Body Irradiation on T Cell Immune Function in Mice. Advances in Clinical Medicine 12:04, pages 2519-2526.
Crossref

Shawn P. Kubli, Thorsten Berger, Daniel V. Araujo, Lillian L. Siu & Tak W. Mak. (2021) Beyond immune checkpoint blockade: emerging immunological strategies. Nature Reviews Drug Discovery 20:12, pages 899-919.
Crossref

Allison B. Powell, Yanqin Ren, Maria Korom, Devin Saunders, Patrick J. Hanley, Harris Goldstein, Douglas F. Nixon, Catherine M. Bollard, Rebecca M. Lynch, R. Brad Jones & Conrad Russell Y. Cruz. (2020) Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV. Molecular Therapy - Methods & Clinical Development 19, pages 78-88.
Crossref

Astero Klampatsa, Michael S. Leibowitz, Jing Sun, Maria Liousia, Evguenia Arguiri & Steven M. Albelda. (2020) Analysis and Augmentation of the Immunologic Bystander Effects of CAR T Cell Therapy in a Syngeneic Mouse Cancer Model. Molecular Therapy - Oncolytics 18, pages 360-371.
Crossref

Kumudhini Preethi Haran, Alexandra Lockhart, Ailian Xiong, Enrico Radaelli, Patrick J. Savickas, Avery Posey & Nicola J. Mason. (2020) Generation and Validation of an Antibody to Canine CD19 for Diagnostic and Future Therapeutic Purposes. Veterinary Pathology 57:2, pages 241-252.
Crossref

Mohit Sachdeva, Brian W. Busser, Sonal Temburni, Billal Jahangiri, Anne-Sophie Gautron, Alan Maréchal, Alexandre Juillerat, Alan Williams, Stéphane Depil, Philippe Duchateau, Laurent Poirot & Julien Valton. (2019) Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality. Nature Communications 10:1.
Crossref

Jin Zhang, Stefan Endres & Sebastian Kobold. (2019) Enhancing tumor T cell infiltration to enable cancer immunotherapy. Immunotherapy 11:3, pages 201-213.
Crossref

Clemens Reinshagen, Deepak Bhere, Sung Hugh ChoiStefan HuttenIrina NesterenkoHiroaki Wakimoto, Eloi Le Roux, Alia RizviWanlu Du, Charles MinicucciKhalid Shah. (2018) CRISPR-enhanced engineering of therapy-sensitive cancer cells for self-targeting of primary and metastatic tumors. Science Translational Medicine 10:449.
Crossref

Xinglong Qu, Ying Tang & Shucheng Hua. (2018) Immunological Approaches Towards Cancer and Inflammation: A Cross Talk. Frontiers in Immunology 9.
Crossref

苏娟陈. (2018) Clinical Observation of Immunization Maintenance Treatment with Thymosin Alpha-1 (Tα1) on Postoperative Lung Cancer with High Risk Recurrence. Asian Case Reports in Oncology 07:04, pages 68-72.
Crossref

Abir K. Panda, Sayantan Bose, Tania Sarkar, Dia Roy, Dwaipayan Chakraborty, Sreeparna Chakraborty, Irene Sarkar & Gaurisankar Sa. (2017) Cancer-immune therapy: restoration of immune response in cancer by immune cell modulation. The Nucleus 60:2, pages 93-109.
Crossref

Robert Sackstein, Tobias Schatton & Steven R Barthel. (2017) T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy. Laboratory Investigation 97:6, pages 669-697.
Crossref

Carmen S M Yong, Valerie Dardalhon, Christel Devaud, Naomi Taylor, Phillip K Darcy & Michael H Kershaw. (2017) CAR T‐cell therapy of solid tumors. Immunology & Cell Biology 95:4, pages 356-363.
Crossref

K Mølgaard, M Compte, N Nuñez-Prado, S L Harwood, L Sanz & L Alvarez-Vallina. (2017) Balanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity. Gene Therapy 24:4, pages 208-214.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumors

Articles from other publishers (16)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumors

Citations (16)

Articles from other publishers (16)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date